ACRV
Price
$2.36
Change
-$0.00 (-0.00%)
Updated
Nov 28 closing price
Capitalization
74.47M
Intraday BUY SELL Signals
AURA
Price
$6.60
Change
+$0.22 (+3.45%)
Updated
Nov 28 closing price
Capitalization
405.47M
122 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACRV vs AURA

Header iconACRV vs AURA Comparison
Open Charts ACRV vs AURABanner chart's image
Acrivon Therapeutics
Price$2.36
Change-$0.00 (-0.00%)
Volume$295.54K
Capitalization74.47M
Aura Biosciences
Price$6.60
Change+$0.22 (+3.45%)
Volume$217.17K
Capitalization405.47M
ACRV vs AURA Comparison Chart in %
ACRV
Daily Signal:
Gain/Loss:
AURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACRV vs. AURA commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a StrongBuy and AURA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 29, 2025
Stock price -- (ACRV: $2.36 vs. AURA: $6.60)
Brand notoriety: ACRV and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 38% vs. AURA: 88%
Market capitalization -- ACRV: $74.47M vs. AURA: $405.47M
ACRV [@Biotechnology] is valued at $74.47M. AURA’s [@Biotechnology] market capitalization is $405.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 1 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 1 green, 4 red.
According to our system of comparison, ACRV is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 4 TA indicator(s) are bullish while AURA’s TA Score has 4 bullish TA indicator(s).

  • ACRV’s TA Score: 4 bullish, 4 bearish.
  • AURA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACRV is a better buy in the short-term than AURA.

Price Growth

ACRV (@Biotechnology) experienced а +2.61% price change this week, while AURA (@Biotechnology) price change was +21.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

AURA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($405M) has a higher market cap than ACRV($74.5M). AURA YTD gains are higher at: -19.708 vs. ACRV (-60.797). ACRV has higher annual earnings (EBITDA): -93.21M vs. AURA (-107.51M). AURA has more cash in the bank: 177M vs. ACRV (137M). ACRV has less debt than AURA: ACRV (3.26M) vs AURA (18.1M). ACRV (0) and AURA (0) have equivalent revenues.
ACRVAURAACRV / AURA
Capitalization74.5M405M18%
EBITDA-93.21M-107.51M87%
Gain YTD-60.797-19.708308%
P/E RatioN/AN/A-
Revenue00-
Total Cash137M177M77%
Total Debt3.26M18.1M18%
TECHNICAL ANALYSIS
Technical Analysis
ACRVAURA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signal:
Gain/Loss:
AURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POAHF42.200.69
+1.66%
Porsche Automobile Holding SE
NVLHF0.13N/A
+0.80%
Nevada Lithium Resources Inc.
JGSMY7.57N/A
N/A
JG Summit Holdings, Inc.
OMTK0.01N/A
N/A
Omnitek Engineering Corp.
SEIGF14.86N/A
N/A
Semperit Ag Holding

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
N/A
ALLR - ACRV
48%
Loosely correlated
+6.40%
AURA - ACRV
39%
Loosely correlated
+3.45%
CRBU - ACRV
37%
Loosely correlated
+3.19%
IPSC - ACRV
36%
Loosely correlated
+0.98%
LXEO - ACRV
35%
Loosely correlated
+2.39%
More